Company / Operating Cash Flow
Mind Medicine (MindMed) Inc. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$131.6M
FY2025
5-year range
-$131.6M / -$45.8M
FY2021-FY2025
Trend
-66.3%
vs FY2024
Sector context
#141 of 216
Health Care
What the data says
At -$132M, Mind Medicine (MindMed) Inc.'s operating cash flow ranks #141 of 216 in the Health Care sector. Operating Cash Flow has declined for 6 consecutive years, from -$3M in FY2019 to -$132M in FY2025.
Based on SEC 10-K filings.
-$132M in FY2025.
Declined from -$64M to -$132M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 216 in Health CareTop 65% of 216This company -$131.6M Sector average $658.7M
▼
-120.0% below sector average
Key checks
Key Insights
- Mind Medicine (MindMed) Inc.'s operating cash flow has declined for 6 consecutive years.
- In FY2025, operating cash flow decreased 66.3% year-over-year.
- Ranks #141 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$131.6M | -66.3% |
| FY2024 | -$79.1M | -22.9% |
| FY2023 | -$64.4M | -28.4% |
| FY2022 | -$50.1M | -9.4% |
| FY2021 | -$45.8M | -94.2% |
| FY2020 | -$23.6M | -637.6% |
| FY2019 | -$3.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026